Septerna (SEPN) Accumulated Expenses (2023 - 2026)

Septerna's (SEPN) quarterly Accumulated Expenses came in at $801000.0 in Q1 2026, down 81.59% year-on-year from $4.4 million in Q1 2025, and up 151.1% quarter-over-quarter from $319000.0 in Q4 2025.

Septerna (SEPN) Accumulated Expenses (2023 - 2026) Analysis & Trends

Septerna's Accumulated Expenses history runs 4 years deep, the most recent figure standing at $801000.0 for Q1 2026.

  • On a quarterly basis, Accumulated Expenses fell 81.59% year-over-year to $801000.0 in Q1 2026; TTM through Mar 2026 was $801000.0, a 81.59% decrease from a year earlier, with the FY2025 full-year figure at $319000.0, down 95.91% from the prior year.
  • Accumulated Expenses advanced to $801000.0 in Q1 2026 per SEPN's latest filing, from $319000.0 in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $7.8 million in Q3 2025 and bottomed at $249000.0 in Q2 2025.
  • The 4-year median for Accumulated Expenses is $4.3 million (2023), against an average of $4.0 million.
  • Across the five-year window, Accumulated Expenses jumped 82.32% in 2024 and plunged 95.91% in 2025, its largest moves.
  • Year by year, Accumulated Expenses stood at $4.3 million in 2023, then soared by 82.32% to $7.8 million in 2024, then plunged by 95.91% to $319000.0 in 2025, then soared by 151.1% to $801000.0 in 2026.
  • Per Business Quant, the three latest SEPN Accumulated Expenses figures stand at $801000.0 (Q1 2026), $319000.0 (Q4 2025), and $7.8 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Septerna 1.50 Bn 1.50 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 801,000.00
Dec 31, 2025 319,000.00
Sep 30, 2025 7.83 Mn
Jun 30, 2025 249,000.00
Mar 31, 2025 4.35 Mn
Dec 31, 2024 7.80 Mn
Sep 30, 2024 5.99 Mn
Dec 31, 2023 4.28 Mn